European Heart Journal—Cardiovascular Pharmacotherapy to become fully open access in 2025 | European Heart Journal - Cardiovascular Pharmacotherapy | Oxford Academic

We are pleased to announce a significant milestone in the development of European Heart Journal—Cardiovascular Pharmacotherapy (EHJ-CVP): the Journal's transition to an open access publication model. Since the European Society of Cardiology (ESC) and the ESC Working Group on Cardiovascular Pharmacotherapy launched EHJ-CVP in 2015, its editors, reviewers, and authors have worked together to bring the latest developments in clinical cardiovascular pharmacotherapy to clinicians, physicians, researchers, and policy makers worldwide. Moving to fully open access publishing will help us further this mission.